DEBORAH MCCOY: Open Payments
NPI 1285608372 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 15 payments from 10 companies in 2025. Trend: 2023 $466 · 2024 $503 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $66 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $32 |
| PFIZER INC. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Astellas Pharma US Inc | 1 | $18 |
| Dynavax Technologies Corporation | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $17 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
Products named: Wegovy, JARDIANCE, MOUNJARO, Ozempic, FARXIGA, Veozah, Heplisav-B, The Cologuard Plus Collection Kit.
Industry payments across TX — which companies pay providers there.
